metastatic testicular non-seminomaretroperitoneal lymph node dissectioninduction chemotherapy1.1. Sheinfeld J. The role of adjunctive postchemotherapy surgery for nonseminomatous germ-cell tumors: Current concepts and controversies. Semin Urol Oncol 2002;20(4):262-71.Sheinfeld J. The role of adjunctive postchemotherapy surgery for nonseminomatous germ-cell tumors: Current concepts and controversies. Semin Urol Oncol 2002;20(4):262-71.2.2. Donohue J.P., Rowland R.G., Kopecky K. et al. Correlation of computerized tomographic changes and histological findings in 80 patients having radical retroperitoneal lymph node dissection after chemotherapy for testis cancer. J Urol 1987;137(6):1176-9.Donohue J.P., Rowland R.G., Kopecky K. et al. Correlation of computerized tomographic changes and histological findings in 80 patients having radical retroperitoneal lymph node dissection after chemotherapy for testis cancer. J Urol 1987;137(6):1176-9.3.3. Mulders P.F., Oosterhof G.O., Boetes C. et al. The importance of prognostic factors in the individual treatment of patients with disseminated germ cell tumours. Br J Urol 1990;66(4):425-9.Mulders P.F., Oosterhof G.O., Boetes C. et al. The importance of prognostic factors in the individual treatment of patients with disseminated germ cell tumours. Br J Urol 1990;66(4):425-9.4.4. Toner G.C., Panicek D.M., Heelan R.T. et al. Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection. J Clin Oncol 1990;8:1683-94.Toner G.C., Panicek D.M., Heelan R.T. et al. Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection. J Clin Oncol 1990;8:1683-94.5.5. Steyerberg E.W., Keizer H.J., Fossa S.D. et al. Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups. J Clin Oncol 1995;13: 1177-87.Steyerberg E.W., Keizer H.J., Fossa S.D. et al. Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups. J Clin Oncol 1995;13: 1177-87.6.6. Vergouwe Y., Steyerberg E.W., Foster R.S. et al. Predicting retroperitoneal histology in postchemotherapy testicular germ cell cancer: a model update and multicentre validation with more than 1000 patients. Eur Urol 2007;51(2): 424-32.Vergouwe Y., Steyerberg E.W., Foster R.S. et al. Predicting retroperitoneal histology in postchemotherapy testicular germ cell cancer: a model update and multicentre validation with more than 1000 patients. Eur Urol 2007;51(2): 424-32.7.7. Mandelbaum I., Yaw P.B., Einhorn L.H. et al. The importance of one-stage median sternotomy and retroperitoneal node dissection in disseminated testicular cancer. Ann Thorac Surg 1983;36(5):524-8.Mandelbaum I., Yaw P.B., Einhorn L.H. et al. The importance of one-stage median sternotomy and retroperitoneal node dissection in disseminated testicular cancer. Ann Thorac Surg 1983;36(5):524-8.8.8. Hartmann J.T., Candelaria M., Kuczyk M.A. et al. Comparison of histological results from the resection of residual masses at different sites after chemotherapy for metastatic non-seminomatous germ cell tumours. Eur J Cancer 1997;33: 843-7.Hartmann J.T., Candelaria M., Kuczyk M.A. et al. Comparison of histological results from the resection of residual masses at different sites after chemotherapy for metastatic non-seminomatous germ cell tumours. Eur J Cancer 1997;33: 843-7.9.9. Beck S.D., Foster R.S., Bihrle R. et al. Outcome analysis for patients with elevated serum tumor markers at postchemotherapy retroperitoneal lymph node dissection. J Clin Oncol 2005;23(25):6149-56.Beck S.D., Foster R.S., Bihrle R. et al. Outcome analysis for patients with elevated serum tumor markers at postchemotherapy retroperitoneal lymph node dissection. J Clin Oncol 2005;23(25):6149-56.10.10. Тюляндин С.А. Лечение диссеминированных герминогенных опухолей у мужчин. Дис.... докт. мед. наук. М., 1993.Тюляндин С.А. Лечение диссеминированных герминогенных опухолей у мужчин. Дис.... докт. мед. наук. М., 1993.11.11. Wood D.P. Jr., Herr H.W., Motzer R.J. et al. Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers. Cancer 1992;70(9):2354-7.Wood D.P. Jr., Herr H.W., Motzer R.J. et al. Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers. Cancer 1992;70(9):2354-7.12.12. Eastham J.A., Wilson T.G., Russell C. et al. Surgical resection in patients with nonseminomatous germ cell tumor who fail to normalize serum tumor markers after chemotherapy. Urology 1994;43:74.Eastham J.A., Wilson T.G., Russell C. et al. Surgical resection in patients with nonseminomatous germ cell tumor who fail to normalize serum tumor markers after chemotherapy. Urology 1994;43:74.13.13. Carver B.S., Shayegan B., Motzer R.J. et al. The incidenceand implications of disease outside a modified template in men undergoing post-chemotherapy retroperitoneal lymph node dissection (PCRPLND) for metastatic non-seminomatous germ cell tumors (NSGCT). J Urol 2006;175:192. Abstr 593.Carver B.S., Shayegan B., Motzer R.J. et al. The incidenceand implications of disease outside a modified template in men undergoing post-chemotherapy retroperitoneal lymph node dissection (PCRPLND) for metastatic non-seminomatous germ cell tumors (NSGCT). J Urol 2006;175:192. Abstr 593.14.14. Baniel J., Foster R.S., Rowland R.G. et al. Complications of primary retroperitoneal lymph node dissection. J Urol 1994;152:424-7.Baniel J., Foster R.S., Rowland R.G. et al. Complications of primary retroperitoneal lymph node dissection. J Urol 1994;152:424-7.15.15. Stenning S.P., Parkinson M.C, Fisher C. et al. Postchemotherapy residual masses in germ cell tumor patients content, clinical features, and prognosis. Cancer 2000;83(7):1409-19.Stenning S.P., Parkinson M.C, Fisher C. et al. Postchemotherapy residual masses in germ cell tumor patients content, clinical features, and prognosis. Cancer 2000;83(7):1409-19.16.16. Fox E.P., Weathers T.D., Williams S.D. et al. Outcome analysis for patients with persistent nonteratomatous germ cell tumor in postchemotherapy retroperitoneal lymph node dissections. J Clin Oncol 1993;11(7):1294-9.Fox E.P., Weathers T.D., Williams S.D. et al. Outcome analysis for patients with persistent nonteratomatous germ cell tumor in postchemotherapy retroperitoneal lymph node dissections. J Clin Oncol 1993;11(7):1294-9.17.17. Fizazi K., Dunant A., Oldenburg J. et al. Viable malignant cells after primary chemotherapy for disseminated non-seminomatous germ-cell tumors (NSGCT): An international validation study. J Clin Oncol 2005;23(16):4521.Fizazi K., Dunant A., Oldenburg J. et al. Viable malignant cells after primary chemotherapy for disseminated non-seminomatous germ-cell tumors (NSGCT): An international validation study. J Clin Oncol 2005;23(16):4521.